MFDS — authorised 23 December 2019
- Marketing authorisation holder: ALLERGAN
- Status: likely_approved
🇰🇷 Ubrelvy in South Korea
MFDS authorised Ubrelvy on 23 December 2019
Marketing authorisation
Ubrelvy in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Ubrelvy approved in South Korea?
Yes. MFDS authorised it on 23 December 2019.
Who is the marketing authorisation holder for Ubrelvy in South Korea?
ALLERGAN holds the South Korean marketing authorisation.